Haplotypes of the estrogen receptor beta gene and breast cancer risk.

Haplotypes of the estrogen receptor beta gene and breast cancer risk.

Exposure to exogenous (oral contraceptives, postmenopausal hormone therapy) and endogenous (number of ovulatory cycles, adiposity) steroid hormones is associated with breast cancer risk. Breast cancer risk associated with these exposures could hypothetically be modified by genes in the steroid hormo...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Cox, D, Bretsky, P, Kraft, P, Pharoah, P, Albanes, D, Altshuler, D, Amiano, P, Berglund, G, Boeing, H, Buring, J, Burtt, N, Calle, E, Canzian, F, Chanock, S, Clavel-Chapelon, F, Colditz, G, Feigelson, H, Haiman, C, Hankinson, SE, Hirschhorn, J, Henderson, B, Hoover, R, Hunter, D, Kaaks, R, Kolonel, L
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008

Documenti analoghi

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
di: Cox, D, et al.
Pubblicazione: (2006)

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
di: Haiman, C, et al.
Pubblicazione: (2007)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
di: Setiawan, V, et al.
Pubblicazione: (2007)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
di: Schumacher, F, et al.
Pubblicazione: (2007)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
di: Chen, Y, et al.
Pubblicazione: (2007)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
di: Ahn, J, et al.
Pubblicazione: (2009)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
di: Travis, R, et al.
Pubblicazione: (2009)

Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
di: Gu, F, et al.
Pubblicazione: (2010)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
di: Patel, A, et al.
Pubblicazione: (2008)

Genetic variation in the HSD17B1 gene and risk of prostate cancer.
di: Kraft, P, et al.
Pubblicazione: (2005)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
di: Koutros, S, et al.
Pubblicazione: (2010)

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
di: Joshi, A, et al.
Pubblicazione: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
di: Lindström, S, et al.
Pubblicazione: (2010)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
di: Campa, D, et al.
Pubblicazione: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
di: Campa, D, et al.
Pubblicazione: (2011)

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the Multiethnic Cohort
di: Altshuler David, et al.
Pubblicazione: (2007-12-01)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
di: Lund Eiliv, et al.
Pubblicazione: (2009-07-01)

High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people.
di: Florez, J, et al.
Pubblicazione: (2006)

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
di: Tsilidis, K, et al.
Pubblicazione: (2013)

Genetic variation in the HSD17B1 gene and risk of prostate cancer.
di: Peter Kraft, et al.
Pubblicazione: (2005-11-01)

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
di: Wolpin, B, et al.
Pubblicazione: (2010)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
di: Campa, D, et al.
Pubblicazione: (2012)

The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk.
di: Annamaria Pezzotti, et al.
Pubblicazione: (2009-01-01)

Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study.
di: Abbas, S, et al.
Pubblicazione: (2014)

Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: The EPIC-InterAct study
di: Abbas, S, et al.
Pubblicazione: (2014)

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
di: Schumacher, F, et al.
Pubblicazione: (2010)

A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study.
di: Paracchini, S, et al.
Pubblicazione: (2003)

Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2.
di: Prokunina-Olsson, L, et al.
Pubblicazione: (2010)

Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height.
di: Hirschhorn, J, et al.
Pubblicazione: (2001)

Linkage disequilibrium at PPARG and other genes assessed with dense sets of SNPs..
di: Hirschhorn, J, et al.
Pubblicazione: (2001)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
di: Barrdahl, M, et al.
Pubblicazione: (2014)

A Genome-wide Pleiotropy Scan for Prostate Cancer Risk.
di: Panagiotou, O, et al.
Pubblicazione: (2015)

Adherence to predefined dietary patterns and incident type 2 diabetes in European populations: EPIC-InterAct Study
di: Kroeger, J, et al.
Pubblicazione: (2014)

Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival.
di: Cao, Y, et al.
Pubblicazione: (2014)

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
di: Cao, Y, et al.
Pubblicazione: (2014)

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
di: Kote-Jarai, Z, et al.
Pubblicazione: (2011)

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
di: Kote-Jarai, Z, et al.
Pubblicazione: (2011)

Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)
di: Balassiano, K, et al.
Pubblicazione: (2011)

Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
di: Balassiano, K, et al.
Pubblicazione: (2011)

Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study.
di: Brand, J, et al.
Pubblicazione: (2013)